Abstract 23: Somatic mutation of cancer susceptibility genes in acute myeloid leukemia
Anna Brown(South Australia Pathology), Richard J. D’Andrea(South Australia Pathology), Maung Kway Zeya(The University of Adelaide), Mahmoud Bassal(University of South Australia), Ing Soo Tiong(The University of Melbourne), Paul Leo(The University of Queensland), Mhairi Marshall(Translational Research Institute), Alan D. D’Andrea(Dana-Farber Cancer Institute), Sarah Bray(South Australia Pathology), G A Engler(South Australia Pathology), Thomas J. Gonda(University of South Australia), Ian A. Lewis(University of Calgary), James X Gray(Basil Hetzel Institute), Bik To(South Australia Pathology), Andrew H. Wei(The Royal Melbourne Hospital), Brooke Gardiner(Translational Research Institute), Nik Cummings(Monash University)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k